We have investigated the methylation status of the repeat unit of the human ribosomal RNA genes in lung cancer. Using a Southern blot analysis approach we have determined that the non-transcribed region of these genes was generally heavily methylated, while the transcribed region was not methylated in either tumor or normal DNA. Our study also revealed that, in one tumor, the boundary of mosaic methylation of the repeat unit was not distinct. In the same tumor, both the non-transcribed ribosomal spacer region and the L1 interspersed repeat sequences became partially demethylated. In tumor cells, the methylation status of DNA can be altered, but the methylation of subtelomeric repeats was found to be maintained. These results suggest that the mosaic methylation of the repeat unit is not necessarily maintained in tumor DNA, while subtelomeric repeats escape tumor-specific wave of demethylation.
The gene for the human 45S ribosomal RNA (rRNA) precursor molecule, which is processed into 18S, 5.8S, and 28S rRNAs, is present in a 43 kilobase (kb) repeat unit. The copy number is approximately 400 (Schmickel, 1973) , and the unit clusters on the short arms of chromosomes 13, 14, 15, 21, and 22 (Worton et al., 1988) . The unit is comprised of two regions, a transcribed region containing the three rRNA genes (approximately 13 kb) and a non-transcribed spacer (NTS) region approximately 30 kb in length.
Most cytosine residues of CpG dinucleotides are methylated in the human genome. However, a mosaic pattern of CpG methylation of the repeat unit of the rRNA genes has been reported (Brock and Bird, 1997) . The transcribed region and a short stretch of flanking NTS are nonmethylated while most of the NTS region is heavily methylated. The boundaries between these methylated and non-methylated domains are distinct.
We have investigated aberrant methylation of CpG islands in human cancer by analysis of clones in a library of DNA fragments that are highly methylated and enriched by methylated DNA binding column chromatography (M. S., Y. H. C. and T. S., unpublished results). In the course of analyzing this library, we identified the presence of multiple segments of the transcribed region of the rRNA genes. In contrast, DNA fragments derived from the NTS region, which are partially rich in CpG dinucleotides and known to be heavily methylated, were detected in the library at a frequency much lower than expected. These findings prompted us to analyze the methylation status of the repeat unit of the rRNA genes in human lung cancer.
Initially we examined the methylation status of the transcribed region in the tumor DNAs that were used to construct the enriched library. Although DNAs from nine tumor samples were used for library construction, only two samples were available for Southern hybridization due to limitations in the amount of the remaining seven tumor DNAs. High molecular weight DNAs derived from tumors and from a non-cancerous portion of the lung of the same patients (patients 59 and 113) (Shiraishi et al., 1989) were digested with restriction endonuclease Tsp509I, which was used for preparation of the DNA fragments to construct the library. The digests were further treated with the CpG-methylation-insensitive restriction endonuclease MspI or its methylation-sensitive isoschizomer HpaII, and subjected to Southern hybridization using various probes. Probe #514, whose nucleotide sequence was complementary to the transcribed region, detected only faint 1.3-kb bands in Tsp509I/HpaII digests of both tumor and normal DNA (Figure 1A, lane 3 in C and N) . This result indicates that the majority of the transcribed region is not methylated in either normal DNA or tumor DNA. It has been reported that a minor portion of the transcribed region of the repeat units is heavily methylated (Bird and Taggart, 1980; Brock and Bird, 1997) , and our observation of the faint bands coincides with these reported results.
In contrast, when the NTS region was analyzed using probe #653, intense 1.2-kb bands were observed in Tsp509I/HpaII digests of both tumor and normal DNA ( Figure 1B , lanes 3). A faint 0.7-kb band in Tsp509I/HpaII digests of 59C (lane 3) suggests partial demethylation of cytosines within HpaII recognition site(s). These results indicate that the non-transcribed region is generally heavily methylated in both tumor and normal DNA.
Since the mosaic pattern of CpG methylation is a characteristic feature of the repeat unit of the rRNA gene, we further investigated whether mosaic methylation was maintained in tumor DNA. Probe #653 detects a 15 kb HindIII fragment. When the genomic DNA was digested with HindIII/HpaII or HindIII/HhaI, an intense 5.5 kb band was observed in normal DNA (Figure 2A , lanes 3 and 4 in N). This result strongly suggests that there is a sharp boundary of CpG methylation at position(s) approximately 1.5-kb downstream of the transcribed sequence (Figure 2B) ; CpG sequences 3Ј to this point are methylated and CpG sequences 5Ј to this point are not methylated. The mosaic methylation was well-maintained in tumor DNA of patient 113 (Figure 2A ). However, in patient 59, digests of 59C DNA with HindIII/HpaII or HindIII/HhaI showed numerous bands ( Figure 2A , lanes 3 and 4 in 59C). This result indicates that the sharp boundary observed in normal DNA of the same patient was lost in tumor DNA. The generation of small heterogeneous HindIII/HpaII or HindIII/HhaI fragments may suggest that there is a boundary shift toward the NTS region and/or the introduction of sporadic demethylation in the NTS region. The exact meaning of this observation remains to be elucidated. Similar patterns of hybridization were observed when a 0.9-kb MluI fragment of the plasmid pHr21Aa containing a 7.3-kb HindIII/EcoRI fragment of the 3Ј region of the spacer (positions 41060 -41947 of accession number U13369) was used as a probe to map the methylation boundary at the 3Ј end of the spacer. The sharp boundary observed in normal DNA of patient 59 was lost in tumor DNA of the same patient, while the mosaic pattern of methylation was maintained in tumor DNA of patient 113 (data not shown).
Demethylation of various kinds of repetitive sequences has been reported in many human cancers. We therefore extended our studies to examine by Southern hybridization the methylation status of subtelomeric repeats and L1 sequences. Subtelomeric repeats are CpG-rich sequences located at the telomeric regions of human chromosomes, and are known to be heavily methylated (de Lange et al., 1990; Brown et al., 1990) . These features are similar to those of some sections of the NTS region. When subtelomeric repeat fragment pMBDL45 was used as a probe, several bands were detected in the digests with Tsp509I/HpaII, and the size of these fragments was longer than those of Tsp509I/MspI digests both in tumor and normal DNA ( Figure 3A, lanes 2 and 3) . These results suggest that the sequences are methylated in normal DNA and no apparent gross alteration of methylation status occurs in tumor DNA.
L1 sequences are known to be distributed throughout the genome, however their preferential presence in Gbands has been reported (Korenberg and Rykowski, 1988) . Methylation status of L1 sequences would be an approximate indicator of methylation of the genome. CpG residues within L1 sequences are usually extensively methylated, however, their demethylation has been reported in various human tumors such as urothelial carcinoma (Jurgens et al., 1996) , colon cancer and leukemia (Dante et al., 1992) . When 113C DNA was digested with HindIII or HindIII/HpaII, an L1 probe, pUK31A, detected a similar smearing pattern in the digests ( Figure 3B, lanes 1  and 3 of 113C) . However, the pattern of HindIII/HpaII digests of 59C DNA showed a decreased size of the fragments ( Figure 3B, lanes 3 of 59C and 59N) . These results suggest that there is no gross change of methylation status in tumor DNA of patient 113, while in patient 59, demethylation occurred in tumor DNA.
Overall demethylation is a characteristic feature of tumor DNA (for recent reviews, see Baylin et al., 1998; Schmutte and Jones, 1998) . On the other hand, some CpG islands, such as those associated with tumor suppressor genes, are heavily methylated in some tumors, possibly resulting in gene silencing (Baylin et al., 1998; Schmutte and Jones, 1998) . These phenomena suggest that DNA in cancer cells is exposed to both the pressure for methylation and for demethylation. The role of hypomethylation in carcinogenesis has yet to be elucidated. However, it has been reported that methylation is associated with maintenance of genome integrity (Chen et al., 1998). Hypomethylation may cause chromosomal instability and increase mutation rates (Chen et al., 1998) .
There can be two different types of demethylation; passive and active. The former occurs during DNA replication, while the latter is a de novo process. Decreased activity of DNA methyltransferases and/or decreased efficiency of the maintenance of methylation may be responsible for passive demethylation. However, little is known about the molecular mechanism of active, de novo demethylation in human cells, and it is not known whether a single, or a limited number of, machinery mediates all active demethylation reactions. Differential demethylation on various chromosomal loci can possibly be attributed to differences in the involved molecules, such as DNA methyltransferase(s) and demethylase(s).
In this study, we have shown that the mosaic pattern of CpG methylation of the repeat unit of the human ribosomal RNA genes was not necessarily maintained in tumor DNA, possibly reflecting overall demethylation pressures. However, subtelomeric repeats remain methylated even in the same tumor DNA. Although a part of the NTS region and the subtelomeric repeats contain many methyl-CpG pairs, only the latter escaped or are resistant to the wave of demethylation in cancer. Maintenance of methylation at regions such as subtelomeric repeats may be important, for example in stabilizing chromosomes in human cells. Our results indicate that demethylation of genomic DNA in cancer is not an event that occurs at random regions. The L1-specific probe pUK31A contains a 1.8 kb HindIII/EcoRI fragment derived from lambda clone T␤G41 Adams et al., 1980) .
